Capital Investment Advisory Services LLC purchased a new stake in McKesson Co. (NYSE:MCK) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 663 shares of the company’s stock, valued at approximately $73,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Nordea Investment Management AB grew its position in shares of McKesson by 48.8% during the 3rd quarter. Nordea Investment Management AB now owns 3,300,839 shares of the company’s stock worth $437,856,000 after purchasing an additional 1,082,398 shares in the last quarter. Matthew Goff Investment Advisor LLC grew its position in shares of McKesson by 13,239.1% during the 3rd quarter. Matthew Goff Investment Advisor LLC now owns 987,361 shares of the company’s stock worth $7,402,000 after purchasing an additional 979,959 shares in the last quarter. Renaissance Technologies LLC acquired a new position in shares of McKesson during the 3rd quarter worth approximately $92,775,000. Rehmann Capital Advisory Group grew its position in shares of McKesson by 14,640.7% during the 3rd quarter. Rehmann Capital Advisory Group now owns 594,049 shares of the company’s stock worth $4,478,000 after purchasing an additional 590,019 shares in the last quarter. Finally, Baupost Group LLC MA grew its position in shares of McKesson by 33.7% during the 3rd quarter. Baupost Group LLC MA now owns 2,175,700 shares of the company’s stock worth $288,607,000 after purchasing an additional 548,000 shares in the last quarter. Institutional investors and hedge funds own 91.31% of the company’s stock.
In other news, EVP Lori A. Schechter sold 7,700 shares of the company’s stock in a transaction that occurred on Wednesday, January 16th. The shares were sold at an average price of $122.96, for a total transaction of $946,792.00. Following the completion of the sale, the executive vice president now owns 10,000 shares of the company’s stock, valued at approximately $1,229,600. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.87% of the company’s stock.
McKesson (NYSE:MCK) last issued its quarterly earnings results on Thursday, January 31st. The company reported $3.40 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.18 by $0.22. McKesson had a negative net margin of 0.15% and a positive return on equity of 27.83%. The company had revenue of $56.21 billion during the quarter, compared to the consensus estimate of $55.27 billion. During the same quarter in the prior year, the firm posted $3.41 EPS. On average, research analysts forecast that McKesson Co. will post 13.55 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, April 1st. Stockholders of record on Friday, March 1st will be issued a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date of this dividend is Thursday, February 28th. McKesson’s dividend payout ratio (DPR) is presently 12.36%.
A number of brokerages have issued reports on MCK. ValuEngine upgraded shares of McKesson from a “strong sell” rating to a “sell” rating in a research report on Monday, February 4th. Zacks Investment Research upgraded shares of McKesson from a “hold” rating to a “buy” rating and set a $144.00 target price on the stock in a research report on Monday, February 4th. Barclays restated a “hold” rating and set a $130.00 target price on shares of McKesson in a research report on Friday, February 1st. Deutsche Bank upgraded shares of McKesson from a “sell” rating to a “hold” rating and set a $175.00 target price on the stock in a research report on Friday, January 25th. Finally, UBS Group began coverage on shares of McKesson in a research report on Thursday, January 17th. They set a “neutral” rating and a $134.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the company. McKesson presently has an average rating of “Hold” and a consensus target price of $137.99.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Week Herald and is the sole property of of Week Herald. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of US & international copyright & trademark legislation. The original version of this piece of content can be viewed at https://weekherald.com/2019/02/14/663-shares-in-mckesson-co-mck-purchased-by-capital-investment-advisory-services-llc.html.
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Featured Story: How to read a candlestick chart
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.